Lunit
Lunit and Coreline Soft have been tapped to join large-scale cancer screening programs.
The aim is to provide AI-powered cancer risk prediction and independent report generation to help clinicians detect cancer.
Also, Lunit will be supplying its chest X-ray and mammography AI to over 200 clinics in Mexico.
Also, Indian diagnostics chain Redcliffe Labs has rolled out a mobile diabetes risk calculation feature.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
Also, Indian pharmacy chain Zeno Health has acquired online pharmacy startup Tablt Pharmacy.
Also, Canon Medical and Olympus are collaborating on endoscopic ultrasonography.
It has also obtained its third US FDA 510(k) clearance.
Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.
It expects to get a contract shortly to supply its AI solutions in over 170 hospitals across the kingdom.